findmyKOL
Clinical trialNCT01046006CompletedPhase 2Interventional

Bortezomib, Dexamethasone, and Rituximab in Previously Untreated Patients With Waldenstrom's Macroglobulinemia

SponsorMeletios A. DimopoulosEnrollment59Waldenstrom's Macroglobulinemia
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Greece
  • Alexandra Hospital , Department of Clinical Therapeutics

    Athens, Attica, Greece

  • Laikon Hospital

    Athens, Attica, Greece

Netherlands
  • Erasmus Medical Center

    Rotterdam, Netherlands

Spain
  • Hospital Universitario de Salamanca

    Salamanca, Spain

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Bortezomib →
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Mar 2007
Primary completion
30 Nov 2010
Completion
30 Nov 2015
Last update posted
30 Apr 2021
Registered enrollment
59
Registry id
NCT01046006
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.